LaFleur & Godfrey’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.1M | Sell |
30,081
-569
| -2% | -$273K | 1.79% | 18 |
|
|
2026
Q1 | $15.1M | Buy |
30,650
+786
| +3% | +$427K | 1.88% | 17 |
|
|
2025
Q4 | $17.3M | Sell |
29,864
-763
| -2% | -$431K | 2.1% | 14 |
|
|
2025
Q3 | $14.9M | Sell |
30,627
-390
| -1% | -$182K | 1.8% | 19 |
|
|
2025
Q2 | $12.6M | Buy |
31,017
+78
| +0.3% | +$32.6K | 1.57% | 21 |
|
|
2025
Q1 | $15.4M | Buy |
30,939
+1,172
| +4% | +$635K | 2.09% | 15 |
|
|
2024
Q4 | $15.5M | Buy |
29,767
+2,488
| +9% | +$1.37M | 2.12% | 14 |
|
|
2024
Q3 | $16.9M | Sell |
27,279
-222
| -0.8% | -$131K | 2.33% | 12 |
|
|
2024
Q2 | $15.2M | Buy |
27,501
+187
| +0.7% | +$107K | 2.23% | 11 |
|
|
2024
Q1 | $15.9M | Sell |
27,314
-3,741
| -12% | -$2.1M | 2.35% | 11 |
|
|
2023
Q4 | $16.5M | Sell |
31,055
-330
| -1% | -$160K | 2.46% | 9 |
|
|
2023
Q3 | $15.9M | Sell |
31,385
-168
| -0.5% | -$89.5K | 2.54% | 10 |
|
|
2023
Q2 | $16.5M | Buy |
31,553
+1,895
| +6% | +$1.02M | 2.47% | 10 |
|
|
2023
Q1 | $17.1M | Sell |
29,658
-953
| -3% | -$537K | 2.8% | 6 |
|
|
2022
Q4 | $16.9M | Sell |
30,611
-330
| -1% | -$175K | 2.81% | 7 |
|
|
2022
Q3 | $15.7M | Sell |
30,941
-1,888
| -6% | -$1.06M | 2.8% | 7 |
|
|
2022
Q2 | $17.8M | Sell |
32,829
-699
| -2% | -$385K | 2.82% | 7 |
|
|
2022
Q1 | $19.8M | Sell |
33,528
-40
| -0.1% | -$23K | 2.66% | 7 |
|
|
2021
Q4 | $22.4M | Sell |
33,568
-1,097
| -3% | -$685K | 2.87% | 7 |
|
|
2021
Q3 | $19.8M | Sell |
34,665
-455
| -1% | -$250K | 2.74% | 7 |
|
|
2021
Q2 | $17.7M | Sell |
35,120
-405
| -1% | -$191K | 2.54% | 8 |
|
|
2021
Q1 | $16.2M | Buy |
35,525
+560
| +2% | +$267K | 3.16% | 7 |
|
|
2020
Q4 | $16.3M | Sell |
34,965
-1,900
| -5% | -$891K | 3.33% | 5 |
|
|
2020
Q3 | $16.3M | Sell |
36,865
-1,685
| -4% | -$696K | 3.67% | 5 |
|
|
2020
Q2 | $14M | Sell |
38,550
-2,187
| -5% | -$733K | 3.57% | 6 |
|
|
2020
Q1 | $11.6M | Sell |
40,737
-315
| -0.8% | -$99.3K | 3.44% | 9 |
|
|
2019
Q4 | $13.3M | Buy |
41,052
+10
| +0% | +$3.03K | 3.01% | 10 |
|
|
2019
Q3 | $12M | Sell |
41,042
-615
| -1% | -$176K | 2.93% | 11 |
|
|
2019
Q2 | $12.2M | Sell |
41,657
-140
| -0.3% | -$38.6K | 3.05% | 13 |
|
|
2019
Q1 | $11.4M | Buy |
41,797
+5,195
| +14% | +$1.29M | 2.95% | 13 |
|
|
2018
Q4 | $8.19M | Buy |
36,602
+45
| +0.1% | +$10.6K | 2.31% | 16 |
|
|
2018
Q3 | $8.92M | Buy |
36,557
+600
| +2% | +$138K | 2.15% | 19 |
|
|
2018
Q2 | $7.45M | Buy |
35,957
+11,242
| +45% | +$2.39M | 1.86% | 25 |
|
|
2018
Q1 | $5.1M | Buy |
+24,715
| New | +$5.19M | 1.28% | 30 |
|
Other funds holding TMO
LaFleur & Godfrey's TMO Position: Q2 2026 in Review
LaFleur & Godfrey reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $273K and leaving 30,081 shares worth $15.1M. The position accounts for 1.79% of the portfolio, ranked #18.
LaFleur & Godfrey first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. The position peaked at $22.4M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- LaFleur & Godfrey held 30,081 shares of Thermo Fisher Scientific worth $15.1M as of Q2 2026.
- LaFleur & Godfrey sold 569 Thermo Fisher Scientific shares in Q2 2026, an estimated $273K.
- Thermo Fisher Scientific made up 1.79% of LaFleur & Godfrey's portfolio in Q2 2026, its #18 holding.
- LaFleur & Godfrey first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
- LaFleur & Godfrey's Thermo Fisher Scientific position peaked at $22.4M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.